FHA
AUPH icon

Flagship Harbor Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Flagship Harbor Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Buy
+38,378
New +$613K 0.02% 443

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Flagship Harbor Advisors's AUPH Position: Q2 2026 in Review

Flagship Harbor Advisors opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 38,378 shares worth $651K. The stake represents 0.02% of the portfolio and ranks #443 among its holdings.

42 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Flagship Harbor Advisors held 38,378 shares of Aurinia Pharmaceuticals worth $651K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Flagship Harbor Advisors position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.02% of Flagship Harbor Advisors's portfolio in Q2 2026, its #443 holding.
  • 42 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.